vs

Side-by-side financial comparison of Claritev Corp (CTEV) and MASIMO CORP (MASI). Click either name above to swap in a different company.

MASIMO CORP is the larger business by last-quarter revenue ($371.5M vs $246.6M, roughly 1.5× Claritev Corp). MASIMO CORP runs the higher net margin — -27.0% vs -32.7%, a 5.7% gap on every dollar of revenue. On growth, Claritev Corp posted the faster year-over-year revenue change (6.2% vs -26.4%). MASIMO CORP produced more free cash flow last quarter ($50.9M vs $36.4M). Over the past eight quarters, Claritev Corp's revenue compounded faster (2.5% CAGR vs -17.7%).

Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets.

CTEV vs MASI — Head-to-Head

Bigger by revenue
MASI
MASI
1.5× larger
MASI
$371.5M
$246.6M
CTEV
Growing faster (revenue YoY)
CTEV
CTEV
+32.6% gap
CTEV
6.2%
-26.4%
MASI
Higher net margin
MASI
MASI
5.7% more per $
MASI
-27.0%
-32.7%
CTEV
More free cash flow
MASI
MASI
$14.5M more FCF
MASI
$50.9M
$36.4M
CTEV
Faster 2-yr revenue CAGR
CTEV
CTEV
Annualised
CTEV
2.5%
-17.7%
MASI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CTEV
CTEV
MASI
MASI
Revenue
$246.6M
$371.5M
Net Profit
$-80.6M
$-100.4M
Gross Margin
62.1%
Operating Margin
-3.1%
22.5%
Net Margin
-32.7%
-27.0%
Revenue YoY
6.2%
-26.4%
Net Profit YoY
41.6%
-1124.5%
EPS (diluted)
$-4.88
$-1.84

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTEV
CTEV
MASI
MASI
Q4 25
$246.6M
Q3 25
$246.0M
$371.5M
Q2 25
$241.6M
$370.9M
Q1 25
$231.3M
$372.0M
Q4 24
$232.1M
$600.7M
Q3 24
$230.5M
$504.6M
Q2 24
$233.5M
$496.3M
Q1 24
$234.5M
$492.8M
Net Profit
CTEV
CTEV
MASI
MASI
Q4 25
$-80.6M
Q3 25
$-69.8M
$-100.4M
Q2 25
$-62.6M
$51.3M
Q1 25
$-71.3M
$-170.7M
Q4 24
$-138.0M
$-349.6M
Q3 24
$-391.4M
$9.8M
Q2 24
$-576.7M
$16.0M
Q1 24
$-539.7M
$18.9M
Gross Margin
CTEV
CTEV
MASI
MASI
Q4 25
Q3 25
62.1%
Q2 25
62.9%
Q1 25
62.9%
Q4 24
40.7%
Q3 24
52.2%
Q2 24
51.3%
Q1 24
49.0%
Operating Margin
CTEV
CTEV
MASI
MASI
Q4 25
-3.1%
Q3 25
4.1%
22.5%
Q2 25
6.9%
17.4%
Q1 25
4.2%
21.0%
Q4 24
-17.8%
-59.8%
Q3 24
-146.7%
6.0%
Q2 24
-224.4%
5.7%
Q1 24
-207.4%
6.9%
Net Margin
CTEV
CTEV
MASI
MASI
Q4 25
-32.7%
Q3 25
-28.4%
-27.0%
Q2 25
-25.9%
13.8%
Q1 25
-30.8%
-45.9%
Q4 24
-59.4%
-58.2%
Q3 24
-169.8%
1.9%
Q2 24
-247.0%
3.2%
Q1 24
-230.1%
3.8%
EPS (diluted)
CTEV
CTEV
MASI
MASI
Q4 25
$-4.88
Q3 25
$-4.23
$-1.84
Q2 25
$-3.81
$0.94
Q1 25
$-4.38
$-3.12
Q4 24
$-8.49
$-6.54
Q3 24
$-24.25
$0.18
Q2 24
$-35.78
$0.29
Q1 24
$-33.40
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTEV
CTEV
MASI
MASI
Cash + ST InvestmentsLiquidity on hand
$16.8M
$312.3M
Total DebtLower is stronger
$4.6B
$559.1M
Stockholders' EquityBook value
$-173.9M
$810.0M
Total Assets
$4.9B
$1.8B
Debt / EquityLower = less leverage
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTEV
CTEV
MASI
MASI
Q4 25
$16.8M
Q3 25
$39.2M
$312.3M
Q2 25
$56.4M
$149.6M
Q1 25
$23.1M
$130.8M
Q4 24
$16.8M
$177.6M
Q3 24
$86.6M
$158.5M
Q2 24
$48.8M
$129.6M
Q1 24
$58.7M
$157.6M
Total Debt
CTEV
CTEV
MASI
MASI
Q4 25
$4.6B
Q3 25
$4.5B
$559.1M
Q2 25
$4.5B
$613.7M
Q1 25
$4.5B
$651.0M
Q4 24
$4.5B
$765.2M
Q3 24
$4.5B
$772.6M
Q2 24
$4.5B
$781.6M
Q1 24
$4.5B
$876.0M
Stockholders' Equity
CTEV
CTEV
MASI
MASI
Q4 25
$-173.9M
Q3 25
$-101.8M
$810.0M
Q2 25
$-39.9M
$1.0B
Q1 25
$14.8M
$946.4M
Q4 24
$84.0M
$1.1B
Q3 24
$207.6M
$1.5B
Q2 24
$603.4M
$1.4B
Q1 24
$1.2B
$1.4B
Total Assets
CTEV
CTEV
MASI
MASI
Q4 25
$4.9B
Q3 25
$5.0B
$1.8B
Q2 25
$5.1B
$2.4B
Q1 25
$5.1B
$2.3B
Q4 24
$5.2B
$2.6B
Q3 24
$5.3B
$3.1B
Q2 24
$5.7B
$2.9B
Q1 24
$6.4B
$3.0B
Debt / Equity
CTEV
CTEV
MASI
MASI
Q4 25
Q3 25
0.69×
Q2 25
0.59×
Q1 25
304.87×
0.69×
Q4 24
53.67×
0.73×
Q3 24
21.73×
0.53×
Q2 24
7.48×
0.57×
Q1 24
3.85×
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTEV
CTEV
MASI
MASI
Operating Cash FlowLast quarter
$66.3M
$56.8M
Free Cash FlowOCF − Capex
$36.4M
$50.9M
FCF MarginFCF / Revenue
14.8%
13.7%
Capex IntensityCapex / Revenue
12.1%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M
$191.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTEV
CTEV
MASI
MASI
Q4 25
$66.3M
Q3 25
$19.9M
$56.8M
Q2 25
$61.2M
$69.4M
Q1 25
$-30.1M
$31.1M
Q4 24
$-33.4M
$50.5M
Q3 24
$72.8M
$25.6M
Q2 24
$18.5M
$74.5M
Q1 24
$49.7M
$45.8M
Free Cash Flow
CTEV
CTEV
MASI
MASI
Q4 25
$36.4M
Q3 25
$-16.3M
$50.9M
Q2 25
$36.6M
$65.6M
Q1 25
$-68.9M
$28.5M
Q4 24
$-63.8M
$46.0M
Q3 24
$41.1M
$16.9M
Q2 24
$-7.0M
$66.9M
Q1 24
$19.2M
$37.6M
FCF Margin
CTEV
CTEV
MASI
MASI
Q4 25
14.8%
Q3 25
-6.6%
13.7%
Q2 25
15.2%
17.7%
Q1 25
-29.8%
7.7%
Q4 24
-27.5%
7.7%
Q3 24
17.8%
3.3%
Q2 24
-3.0%
13.5%
Q1 24
8.2%
7.6%
Capex Intensity
CTEV
CTEV
MASI
MASI
Q4 25
12.1%
Q3 25
14.7%
1.6%
Q2 25
10.2%
1.0%
Q1 25
16.8%
0.7%
Q4 24
13.1%
0.7%
Q3 24
13.8%
1.7%
Q2 24
10.9%
1.5%
Q1 24
13.0%
1.7%
Cash Conversion
CTEV
CTEV
MASI
MASI
Q4 25
Q3 25
Q2 25
1.35×
Q1 25
Q4 24
Q3 24
2.61×
Q2 24
4.66×
Q1 24
2.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons